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A LITERATURE REVIEW OF PLANTAR FASCIITIS  
 
JACOB BAIR DIAMOND 
ABSTRACT 
 Estimates show that roughly 2 million people around the world present 
with chronic plantar heel pain each year, of which the number one cause is 
plantar fasciitis. The degree of this pain ranges from obnoxious to debilitating 
and often features a progressive worsening of symptoms. If mistreated or simply 
left untreated, it can leave athletes sidelined from their respective sports 
indefinitely, and anyone whose occupation requires extended weight bearing 
activity fighting through enormous levels of pain to perform their duties. Plantar 
fasciitis arises more often in certain populations than others, and the reasons 
behind these correlations are highlighted and explored here. This condition 
causes a significant amount of frustration from both patients and physicians 
alike, because it is difficult to diagnose as a variety of differential diagnoses 
cause a similar type of pain. This paper discusses the most critical signs in 
determining whether or not a patient is dealing with plantar fasciitis, as well as 
reviewing the treatment options recommended, which depend on the extent to 
which microtear damage has occurred. A hindrance to appropriate care for 
  vii
patients exists, perhaps due to inconsistencies in the understanding of plantar 
fasciitis and the language used to describe it. Here the ability of physicians to 
eliminate almost entirely the use of painful, costly procedures and help patients 
return to weight bearing activities pain-free is discussed. 
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INTRODUCTION 
Plantar fasciitis, the most common cause of chronic plantar heel pain 
(CPHP) is prevalent in 10% of the US population and makes up 10% of all 
running-related injuries (Melvin et al., 2015). Unlike typical soft tissue injuries 
there rarely exists an acute incident that causes plantar fasciitis. As a result, the 
gradual, slow buildup of symptoms can lead to patients failing to present to 
clinicians until the plantar fascia has undergone significant damage. This, 
combined with somewhat confusing language surrounding the disorder, as well 
as inconsistent, subjective diagnostic techniques, makes plantar fasciitis a 
challenging condition for physicians and patients.  
 
The Incidence of Plantar Fasciitis 
CPHP constitutes the reason for more visits to healthcare professionals 
than any other lower-extremity injury with multifactorial causes (Ortega-Avila et 
al., 2016). Heel pain can result from many diagnoses ranging from neurologic 
causes (tarsal tunnel syndrome), skeletal causes (Paget’s disease), and most 
commonly, soft tissue complications such as painful heel syndrome. Plantar 
fasciitis is another example of a soft tissue complication and is widely recognized 
as the most common cause of such heel discomfort. It is estimated that nearly 2 
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million patients worldwide are treated for plantar fasciitis annually, and that 
diagnosis is the reason behind an estimated 80% of heel pain (Melvin et al., 2015) 
(Kadakia, 2010).  
 
Plantar Fascia “microtear” Physiology 
Plantar fasciitis is clinically described as inflammation of the plantar fascia 
(aponeurosis), presenting as pain at the insertion of the tissue to the tuberosity of 
the calcaneus. The fascia stretches from the heel to the metatarsal bones (in the 
toes). This tissue provides stationary support as well as dynamic shock support 
for the medial longitudinal arch (MLA), so if symptoms are allowed to worsen 
after onset, the entire structural integrity of the foot’s walking motion can be 
compromised (Melvin et al., 2015). Although most patients present with isolated, 
acute pain in the region of the medial process of the calcaneal tubercle, pain may 
also extend along the entire length of the plantar fascia (Barrett et al., 1999). 
Indeed, progressive worsening of symptoms over a period of time is almost 
comprehensively experienced by patients presenting with plantar fasciitis, as 
opposed to an acute rupture of the plantar fascia. The physiology behind the 
symptoms will be reported in more detail later, but the symptoms present and 
compound as the body’s ability to repair millions of “microtears” (Figure 1) 
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within the fibrous aponeurosis cannot compete with the incidence of new tears 
(Young et al., 2001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Illustration of microtears. Microtears of the plantar fascia result from 
collagen degeneration in the fibrous connective tissue of the ligament (taken 
from Young et al., 2001) 
 
These microtears often arise at the area of insertion of aponeurosis to 
calcaneus, the calcanealfascial interface, but with continued weight bearing and 
lack of therapy, microtears may develop along the length of the tissue. Elite, 
professional athletes remain at the highest risk for experiencing the rare acute 
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rupture of the ligament, however prognosis for such an injury is quite positive; 
many athletes are able to return to a full load of physical activity in nine weeks 
following a non-invasive treatment plan including a cast-boot, some period of 
non-weight bearing and physical therapy (Saxena, 2004).  
 
Risk Factors 
General obesity, including sudden weight gain, has been identified as an 
important risk factor; a recent study determined that body mass index (BMI) is 
the most predictable variable of plantar fasciitis, with a BMI equal to or greater 
than 30 showing significantly increased incidence of the condition (Ortega-Avila 
et al., 2016). Contrastingly, excessive weight bearing activity, such as regular 
long distance running and other athletic movement causes more stress on the 
plantar fascia and has been linked to plantar fasciitis. The plantar fascia has long 
been credited with providing support for the foot and is the main contributor to 
the shape of the foot’s arch, specifically the MLA. Those with pes cavus, an 
extremely high MLA (Burns et al., 2005), as well as those with pes planus, an 
exceedingly low arch or ‘flat-foot’, have both been found to be at increased risk 
for developing the symptoms of plantar fasciitis (Young et al., 2001). These 
seemingly contradictory risk factors provide a variety of patients affected by this 
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condition and it appears to be a textbook example of an injury with multifactorial 
causation.  
Diagnosis and Treatment 
Because the symptoms of plantar fasciitis can vary in severity from 
irritating to debilitating, an equally broad assortment of treatment options exists 
to remedy the condition. Many physicians and patients opt for conservative 
treatments before turning to invasive procedures, especially when the patient 
presents with less severe symptoms. Plantar fasciitis has proven to be incredibly 
correctable with conservative treatments when diagnosed early in its course. This 
paper will explore several treatment options for varying levels of severity of the 
injury including assorted stretching techniques, orthotics and similar arch 
supports, as well as corticosteroid injections and even a recently studied 
alternative type of injection. The physiological mechanisms behind these 
procedures will be detailed, along with their rates of success and associated risks. 
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Outline and Specific Aims 
In the first part of this thesis, the incidence of plantar fasciitis within the 
general population will be explored, along with several recognized risk factors 
for the condition. Next, its physiological and biochemical mechanisms will be 
discussed. And finally, the clinical diagnosis and prognosis of varying levels of 
severity of the injury will be detailed before reviewing different treatment 
options available at those stages. 
 
Specific aims of the following thesis include: 
1. Comprehensive review of literature to provide an inclusive understanding 
of plantar fasciitis including the incidence, physiological mechanisms, and 
risk factors of the condition. 
2. Investigation of a wide variety of treatment methods ranging from 
conservative to invasive. 
3. Conclusion on the most effective means of treating plantar fasciitis as well 
as its prevention. 
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PLANTAR FASCIITIS EPIDEMIOLOGY 
 
Incidence within the general population 
As noted in the introduction, medical professionals around the world 
encounter two million cases of plantar fasciitis each year. Although the condition 
can manifest bilaterally, in both feet, it is usually seen unilaterally, and 
surprisingly, half of those two million cases come from the United States alone 
(Lim et al., 2016). According to the National Center for Health Statistics at the 
U.S. Centers for Disease Control and Prevention, most of those patients (sixty-
two percent) present to general medical clinics, with less than one third of total 
cases (31%) being examined by a general or orthopaedic surgeon (Scher et al., 
2009). Patients routinely present to podiatric clinics as well, with a 2009 survey 
from the American Podiatric Medical Association finding that plantar fasciitis 
was the most common malady being treated in podiatric clinics (Scher et al., 
2009). It was estimated that costs to third-party payers suffering from symptoms 
of plantar fasciitis, in 2007 alone, were between $192 and $376 million (Riddle et 
al., 2003). With ten percent of the American population expected to experience 
plantar fasciitis over their lifetime, and that number increasing each year, risk 
factors must be identified to allow those with a higher likelihood of developing 
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the condition to implement preventative measures in order to keep them out of 
the doctors office and footing the bills for various therapies (Riddle et al., 2003).  
 
Contributing Factors 
The greatest level of pain and discomfort people afflicted with plantar 
fasciitis face generally corresponds with weight bearing activities. Pain that 
ranges from mildly irritating to debilitating is almost always made worse with 
continued or excessive weight-bearing activity. For these reasons, plantar fasciitis 
is commonly associated with athletes, however it seems to be widespread in non-
athletic populations as well (Irving et al., 2006). The incidence among women is 
slightly higher, although the reason behind this remains unknown. BMI has 
shown promise as a predictive factor when it comes to risk of all CPHP 
diagnoses. A review of five studies examining the correlation between BMI and 
unilateral plantar fasciitis revealed that four of the studies found a significant 
difference between case groups (patients diagnosed with plantar fasciitis) and 
control groups when it came to BMI. The one study that showed no significant 
difference was attributed to a lack of sufficient sample size (case + control = 10) 
(Irving et al., 2006).  One of the four studies’ results have been reported below, 
and they show that subjects with a BMI of 25 to 30 were twice as likely to  
	9 
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Table 1. Characteristics of Patients and Control Subjects in Relation to Risk of Plantar 
Fasciitis. Comparison of several proposed risk factors between a population (mean age 
of 49 years) diagnosed with plantar fasciitis and a comparable population of those 
without the condition (modified from Riddle et al., 2003). Note the increased incidence 
among subjects with a BMI greater than 30 and limited range of ankle dorsiflexion on 
the involved side (highlighted). (*BMI and ankle dorsiflexion were analyzed as continuous 
variables. The data for dorsiflexion are presented in the table in quartiles, and the data for BMI 
are presented in tertiles. A point at approximately the midrange of each quartile or tertile 
represents the odds ratio for that category. †p < 0.01. ‡p < 0.05. §The involved side of the study 
patient was matched with the same sides (right or left) of the control subjects. #p < 0.001.) 
 
be diagnosed with plantar fasciitis as those with a BMI of less than 25. 
Additionally, developing plantar fasciitis was found to be six times more likely 
in patients with a BMI of 30 or greater (Irving et al., 2006). 
 Along with BMI, extended periods of weight-bearing and restricted ankle 
dorsiflexion were also identified as factors that considerably increased the risk 
for plantar fasciitis, as seen in Table 1. Interestingly, limited ankle dorsiflexion 
on the uninvolved side as well as the involved side of unilateral plantar fasciitis 
proved to be risk factors; 66% of the patient population was found to have 
between zero and five degrees of ankle dorsiflexion on the uninvolved side 
(Table 2) (Riddle et al., 2003). A possible explanation given by the study for this 
correlation involves excessive pronation of the foot during standing and walking.  
This proposed pronation serves as an attempt to compensate for the limited 
ankle dorsiflexion (Riddle et al., 2003). Such a position would increase tensile  
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Table 2. Risk of Plantar Fasciitis Based on Range-of-Motion Data for the Uninvolved 
Side. Comparison of ankle dorsiflexion in the uninvolved side of patients with plantar 
fasciitis and a comparable population of those without the condition (modified from 
Riddle et al., 2003). Note the increased incidence among subjects with limited range of 
ankle dorsiflexion on the uninvolved side (highlighted). (*Data adjusted for BMI, whether 
the person spent the majority of time on their feet at work, and whether the patient was a 
recreational jogger. †Ankle dorsiflexion was analyzed as a continuous variable. The data for 
dorsiflexion are presented in quartiles. A point at approximately the midrange of the quartile 
category represents the odds ratio for that category. ‡The uninvolved side of the case subject was 
matched with the same sides (right or left) of the control subjects. §p < 0.01.) 
 
load on the plantar fascia, which is in accordance with the effects of the other two 
risk factors identified by this study: obesity and prolonged weight bearing. 
Excessive weight bearing may often be unavoidable when it comes to 
certain patient’s careers; plantar fasciitis was originally known as Policeman’s 
Heel, due to a high incidence of CPHP symptoms in active law enforcement. In 
recent decades, recreational running is gaining more popularity worldwide due 
to its proven health benefits, as well as its low cost. At the same time, competitive 
runners and athletes in every sport are training more and running faster and 
longer than ever before. Unfortunately, this trend has coincided with an 
increased incidence of running-related injuries, which have been specifically 
correlated to depend on the number of hours spent running; runner’s heel is 
becoming the new Policeman’s Heel (Lopes et al., 2012).  
Besides the relatively environmental risk factors of obesity and prolonged 
weight bearing, one other congenital designation besides ankle mobility has been 
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explored as a potential risk factor: the posture of the foot. Pes cavus or cavoid 
foot, referring to a foot with an exceptionally high MLA, as well as the 
contrasting condition pes planus, commonly known as flat-foot, have both been 
identified as contributors to the development of plantar heel pain (Figure 2) 
(Young et al., 2001). Bilateral pes cavus affects between 8-15% of the population 
and can be categorized as belonging to one of two etiologies: neurogenic or 
idiopathic (Burns et al., 2005). Of those patients suffering from pes cavus 
(especially that of an idiopathic origin) many will seek relief for foot pain with 
similar symptoms to plantar fasciitis, mainly pressure on the plantar fascia. In a 
study by Burns et al. (2005), it was discovered that patients with a pes cavus foot 
type were almost three times more likely to present with musculoskeletal foot 
pain as those subjects with a normal foot type, and among such foot pain, plantar 
fasciitis was the most common diagnosis, along with metatarsalgia. A proposed 
explanation for the increased incidence of plantar pain in these patients stems 
from differences in contact area, peak pressure, and a pressure-time integral 
when compared to those of a normal foot (while performing a walking motion). 
Compared to the normal foot group, the idiopathic pes cavus group displayed a 
higher peak pressure and a higher pressure-time integral at the rear-foot region, 
as well as significantly less contact area at the mid-foot region (Tables 3 - 5). 
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Table 3. Contact Area in (cm2) when performing a walking motion for the normal foot 
type group, compared to the idiopathic pes cavus group (Burns et al., 2005). All values 
are expressed as mean (standard deviation). * Indicates significant difference compared to the 
normal foot type group (P < 0.05). 
 
 
 
 
 
 
 
 
 
 
Table 4. Peak Pressure in (N/cm2) when performing a walking motion for the normal 
foot type group, compared to the idiopathic pes cavus group (Burns et al., 2005). All 
values are expressed as mean (standard deviation). * Indicates significant difference compared to 
the normal foot type group (P < 0.05). 
 
 
 
 
 
 
 
 
 
 
Table 5. Pressure–time Integral in (N s/cm2) ) when performing a walking motion for 
the normal foot type group, compared to the idiopathic pes cavus group (Burns et al., 
2005). All values are expressed as mean (standard deviation). * Indicates significant difference 
compared to the normal foot type group (P < 0.05). 
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Contrastingly, pes planus, or excessive pronation of the foot, has also been 
linked to plantar fasciitis. While almost all infants are born with flat feet, most 
children lose their baby fat and develop a standard MLA as weight bearing 
activities increase (Pourghasem et al., 2016). A recent cross sectional descriptive 
study on Mississippi school children between the ages of six and 18 found a 
direct correlation between obesity (BMI) and incidence of pes planus; only 13.9% 
of underweight children and 16.1% of normal weight children were found to 
have pes planus compared with 30.8% of obese children (Pourghasem et al., 
2016). Although more prevalent in children, this flat-foot syndrome affects 10–
25% of the adult population and is a common finding among a significant 
percentage of patients who present with CPHP (Angin et al., 2014). An 
apparently unique implication of developing plantar fasciitis in a foot with pes 
planus is a thickened plantar fascia, particularly at the junction of the calcaneus 
bone and fascia: an attempt by the body to counteract the increased stress placed 
on the aponeurosis (Angin et al., 2014). 
 Each risk factor discussed may be associated with the others, and they are 
far from independent. For instance, a patient who develops plantar fasciitis may 
be predisposed to a lack of available ankle dorsiflexion, which is exaggerated by 
their job, in which they stand or walk much more than the average person. Pes 
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planus may develop in a compensatory fashion to help support the ankle’s lack 
of mobility. If this hypothetical patient happens to be overweight, they are 
suddenly associated with every predictive risk factor for plantar fasciitis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Left: Varying Foot-types of the right foot: pes cavus, supination; pes planus, 
pronation. Right: Plantar Flexion of a right foot afflicted with plantar fasciitis (modified 
from Galland, 2013). 
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PLANTAR FASCIITIS PHYSIOLOGY 
 
Plantar Fascia Gross Anatomy 
The plantar fascia extends along the sole of the foot and is widely 
recognized for giving structural support to the MLA, although the name ‘fascia’ 
itself may be misleading. In recent years there has been some discrepancy over 
the classification of the plantar fascia: specifically, some reference it as a true 
fascia, while others categorize it as an aponeurosis. With all definitions coming 
from the Farlex Partner Medical Dictionary, fasciae, aponeuroses, ligaments, and 
tendons all consist of highly organized, tightly packed, dense, regular connective 
tissue, originating from and maintained by fibroblasts. The difference between 
the classifications lies in what structures the connective tissue is joining. While 
fasciae can be defined as tissue that totally envelops a singular muscle or groups 
of muscles, separating them into layers, the designation of aponeurosis may be 
more suited to the commonly referred to ‘plantar fascia’. A solid example of a 
true fascia would be the rectus sheath, a sleeve surrounding the abdominal 
rectus abdominis and pyramidalis muscles. Indeed while the tissue in question 
does interact with the various plantar muscles, it doesn’t truly envelope them, 
making the definition of aponeurosis appear more appropriate; aponeuroses are 
sheet-like extensions of muscles, forming proximal or distal attachment to other 
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muscle or bone and may serve some purposes of a fascia. Henceforth, when 
discussing the plantar fascia, it will be understood that anatomically speaking, 
the tissue serves the purposes of an aponeurosis, and the two terms will be used 
interchangeably. 
The plantar fascia, described upon dissection as a glistening, pearly white 
tissue, separates into three parts: medial, central, and lateral, with the central 
division being the largest and thickest. Beginning at the posterior region of the 
foot, specifically the medial process of the tuberosity of calcaneus, the central 
plantar fascia spreads over the plantar surface of the flexor digitorum brevis 
muscle (Stecco et al., 2013).  Extending along the length of the foot, the central 
part of the tissue concludes anteriorly in five distinct, yet uneven bands, which 
insert and attach to the different proximal phalanges of the toes (see Figure 3) 
(Plantar Fascia Anatomy). The aponeurosis thins as it approaches the posterior 
aspect of the foot, allowing it to envelope the periosteum of the calcaneal bone, 
with which it is continuous in infants but distinct from in adults (Wearing et al., 
2006).  Finally, the fascia becomes continuous with the paratenon of the Achilles 
tendon, possibly explaining why complications with that tendon often overlap 
with those of the plantar fascia (Stecco et al., 2013). 
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Figure 3. Plantar View of Foot Anatomy. Note the central portion of the plantar fascia 
as well as the flexor digitorum brevis (modified from Tatli et al., 2009). 
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Plantar Fascia Histological Anatomy  
 Important to the implications of plantar heel pain is having a basic 
understanding of the composition of the tissue. As noted before there has been 
considerable debate and discrepancy regarding the classification of the plantar 
fascia but recent studies have shown that all ligaments of the foot, once thought 
to be histologically similar, are quite different, biochemically and histologically. 
The central aspect of the aponeurosis is made up of dense, regular connective 
tissue, and therefore, longitudinal arrays of fibroblasts surrounded by an 
extracellular matrix, or ground substance of their own creation. Most of this 
matrix is made up of collagen fibers, organized in a wavy pattern that provides 
rigidity but yields and adjusts with movement. It has been hypothesized that this 
adjustment is made possible as a result of the arrangement of the fibroblasts; 
their highly organized configuration allows for intercellular communication and 
therefore an active sensory organ that can facilitate compositional changes of the 
matrix based on physical demands (Wearing et al., 2006). This means of 
communication is important as the plantar fascia, like most other fibrous 
attachments, is devoid of much vasculature. The aforementioned attachment of 
the aponeurosis to the calcaneus, or enthesis, has been explored as an area of 
interest when it comes to the development of plantar fasciitis. This interest is due 
 21 
to the gradient of tissue that goes from dense connective tissue to bone and is 
thought to play a role in redistributing the brunt of compressive forces at the 
fibrocartilagenous insertion (Wearing et al., 2006). In Figure 4, the gradient of 
tissues at a similar enthesis may be visualized quite distinctly. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Fibrocartilage enthesis. A gradient of tissue from top to bottom of zones: (i) 
dense fibrous connective tissue (not seen), (ii) uncalcified fibrocartilage, (iii) calcified 
fibrocartilage, and (iv) bone (modified from Wearing et al., 2006).   
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Biomechanics  
 In a normal walking motion, the heel is the first part of the foot to make 
contact with the ground surface. Following this initial contact, the tibia rotates 
inward as the foot pronates, simultaneously stretching the plantar fascia while 
compressing the MLA into a more flat position (Roxas, 2005). It is the consensus 
in most literature that repetitively performing this motion can strain a 
predisposed fascia and lead to the condition of fasciitis. As reported in an earlier 
section, athletes are far from the only ones susceptible to developing plantar 
fasciitis. However, many of the studies performed to explore the biomechanics 
behind the condition have focused on populations of active runners, mainly 
because of the increased incidence and those patients’ willingness to participate 
in studies that might produce a positive outcome. Runners also provide a large 
sample size of movement for studies; a run lasting a single hour equates to the 
number of steps (10,000) taken by the average American adult in one day (Pohl et 
al., 2009).  
A 2009 study comparing the biomechanics of female runners with and 
without a history of plantar fasciitis obtained interesting results. As one would 
expect, those with a history of the condition had a greater average degree of 
static midfoot pronation, which falls in line with previous literature. However, 
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contrasting other findings to date, subjects with a history of plantar fasciitis were 
found to have greater passive ankle dorsiflexion range of motion than those 
without it. The differences between the two groups came almost entirely from 
the area of the mid-foot, not the rear-foot, where pain associated with plantar 
fasciitis is generally localized. The researchers hypothesized this to be due to 
their requirement that subjects were pain free (for at least two months) before 
entering the study, and may give evidence to the claim that physical therapy for 
plantar fasciitis can lead to a greater range of motion than was possible before 
treatment. However, vertical impact peaks as well as loading rates, both good 
quantifiers of external loads applied to the foot when running, were found to be 
significantly higher in the group with a history of the condition (Pohl et al., 2009). 
This indicates a greater tendency for subjects with a history to reinjure their 
aponeurosis; it is subjected to greater external forces, which leads to abnormal 
mechanical loading. High vertical load rates (Table 6) are a possible factor 
contributing to the increased incidence of plantar fasciitis among runners 
because previous reports studying walking found no differences in these rates 
between subjects and control groups; this suggests a possible threshold for 
loading rates that are only reached when running (Pohl et al., 2009). 
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Table 6. Mean Kinematic Variables. Results comparing several kinetic factors studied 
in female runners with (PF) and without (CON) a history of plantar fasciitis (modified 
from Pohl et al., 2009). Note the statistically significant increases in impact peak and 
VILR in PF subjects compared with CON group (highlighted). 
*Significant difference between groups (P < 0.05).  
PF, plantar fasciitis group; CON, control group; P, probability of independent t test value; EV, 
eversion; DF, dorsiflexion; BW, body weight; VILR, maximum instantaneous load rate.  
 
Pathogenesis 
 The pathogenesis of plantar fasciitis has long been linked to that of both 
tendinitis and insertitis, inflammation of a tendon or insertion, respectively 
(Wearing et al., 2006). Although microtrauma of the connective tissue is 
continuous with the pathologies of these other conditions, a relatively recent 
observation has led to a new school of thought when it comes to this injury. 
Unlike traditional inflammatory conditions, there seems to be no evidence of an 
inflammatory response when considering plantar fasciitis. A traditional 
inflammatory response usually includes clinical signs of pain, heat, redness, 
swelling, and loss of function, along with the histological presence of 
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polymorphonuclear leukocytes, lymphocytes, or macrophages (Lemont et al., 
2003) (Wearing et al., 2006). Although rubor, calor, and obviously pain or dolor 
will often be a sign of plantar fasciitis, there is little to no evidence of the 
microscopic elements of inflammation in patients with the condition.  
The literature proposes that plantar fasciitis results from an active 
degenerative process, including several key characteristics of the tissue: collagen 
fiber degeneration and disorientation, increased mucoid ground substance, 
angiofibroblastic hyperplasia, and excessive calcification (Wearing et al., 2006). 
These degenerative noninflammatory changes in the fascia suggest a 
pathogenesis of fasciosis rather than fasciitis, more similar to the chronic necrosis 
of tendinosis, or tendon degeneration, than tendinitis (Lemont et al., 2003) 
(Wearing et al., 2006). Table 7 displays the findings of Wearing et al.’s 
comprehensive review of the literature, in which degeneration (including the 
four hallmarks discussed earlier) was found across the board in patients with 
plantar fasciitis compared with an almost total lack of any cellular signs of 
traditional inflammation. This proposed mechanism of pathogenesis also falls in 
accordance with the aforementioned thickening of the central aspect of the 
aponeurosis in patients suffering from plantar fasciitis as a complication of pes 
planus; thickening of the tissue as it nears the insertion point at the calcaneus 
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Table 7. Histopathological findings of patients with plantar fasciitis from several 
studies (modified from Wearing et al., 2006). 
 
may be due to fibrosis, a compensatory mechanism of the tissue to incessant 
microtears. Indeed, Karabay et al. demonstrated that increased thickness of the 
aponeurosis, determined using ultrasound imaging, could be used as a 
diagnostic tool for plantar fasciitis (2007). This designation of the condition as a 
fasciosis rather than a true fasciitis is extremely important as it may cause a 
difference in the way healthcare professionals attempt to treat the condition. 
Furthermore, for the sake of clarity, in this thesis, this examined condition will 
continue to be referred to as plantar fasciitis, but it should be understood that 
this is a misnomer and an issue of tissue degeneration, not inflammation. 
 Although plantar fasciitis has proven to be a prime example of a condition 
with multifactorial causation, repetitive microtrauma of the tissue, consequent 
degeneration of its collagen fibers, and fibrosis are at the root of most cases, 
independent of external risk factors. Additionally, almost all of the literature 
reviewed mentions heightened severity of pain associated with the first steps of a 
patient’s day after rising from a sleeping position, with symptoms often 
gradually diminishing throughout the day, excluding prolonged weight bearing 
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activities. In concert with the theory of plantar fasciitis being a misnomer for a 
noninflammatory disorder, this increased pain in the morning is hypothesized to 
be a result of a healing effort during sleep; as a patient sleeps, and they 
experience plantar flexion, fibrosis occurs in the afflicted tissue. The progress this 
adaptive process makes overnight is insufficient to overcome the loading force of 
the first few steps upon waking, yet it is enough to cause severe pain as the 
newly laid collagen fibers are torn and the degenerative process begins again 
(Young et al., 2001). In a macro view, plantar fasciitis progresses from an acute 
phase to a subacute phase, and finally a chronic phase, and as the condition 
progresses, the options for therapy advance accordingly from conservative to 
more extreme measures including surgery (Jabbari, 2015). In the next section, 
plantar fasciitis diagnosis will be briefly detailed before reviewing the treatment 
options.  
 
 
 
 
 
 
 29 
DIAGNOSTIC TECHNIQUES 
Diagnosis 
 Across the literature, diagnosing plantar fasciitis seems to be an issue. 
With CPHP constituting the reason for so many doctors visits, and a vast range 
of issues underlying this pain, it is important for healthcare professionals to 
identify the correct cause, ensuring a patient isn’t treated by redundant means. 
Table 8 lists a number of differential diagnoses that can present with CPHP. It is  
evident that several of the ‘differentiating’ clinical features used to distinguish 
between causes of CPHP can become muddled and a few of those features have 
been linked to more than one diagnosis. This presents an issue for physicians, for 
while these injuries and disorders often result in a comparable chronic heel pain, 
the etiology and treatment of each condition varies tremendously; indeed a 
common misdiagnosis for plantar fasciitis is a heel spur, or calcium deposit on 
the calcaneus.   
 Adding to the difficult process of identifying plantar fasciitis is the relative 
lack of diagnostic testing and its diagnosis is generally made on a basis of 
retrieving a history along with a clinical examination (Nuhmani et al., 2014). 
However, the literature generally concurs on several diagnostic indications of 
plantar fasciitis; the causation, location, and timing of pain can usually 
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Table 8. Differential Diagnoses of Heel Pain (modified from Young et al., 2001) 
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differentiate plantar fasciitis from other presentations of CPHP. While an injury 
like spontaneous rupture of the plantar fascia is associated with an acute incident 
of trauma, the symptoms of plantar fasciitis present in a contradictory manner; 
most patients see a doctor after a gradual onset of pain that lasts anywhere from 
several weeks to six months before reaching its greatest severity (Singh et al., 
1997). The location of the pain may be the least helpful clinically diagnostic tool, 
for every patient presenting with CPHP will most likely have some form of heel 
pain. However, one unique aspect about plantar fasciitis’ pathology is that, while 
pain will likely be most severe at the inferior position of the medial calcaneal 
tuberosity, it may originate from or spread to the entire length of the 
aponeurosis, and therefore the foot itself (Singh et al., 1997). This migratory 
pattern of pain may set plantar fasciitis apart from similar conditions. But the key 
to distinguishing this condition from other causes of CPHP lies in the timing of 
pain onset.  
 As discussed in the sections on risk factors and pathogenesis, plantar 
fasciitis is caused by excessive force on the affected tissue. When such force is 
absent, not only do the symptoms subside, but a healing process also begins. This 
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occurs for most patients at night, as they sleep. For this reason, patients 
presenting with nocturnal heel pain are often diagnosed with a different cause of 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Plantar Flexion vs. Dorsiflexion. A visual aid to plantar flexion, experienced 
while sleeping, and dorsiflexion, experienced upon initial steps in the morning and 
associated with severe pain in those with plantar fasciitis (Rice). 
 
CPHP (Nuhmani et al., 2014). In plantar fasciitis patients, however, while the 
greatest relief often comes at night, the most intense pain is felt during the first 
several steps of the morning, as well as at the beginning of physical activity 
(Irving et al., 2006). This is due to the plantar flexion (Figure 5) experienced by 
most patients during sleep. While Dr. Robert Smith found evidence that only 
21% of people sleep with their feet in a position of plantar flexion, it is estimated 
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that the vast majority of patients suffering from plantar fasciitis rest with their 
feet in this position, as it provides relief from their symptoms (1985). With the 
foot in that position, the rebuilding fibrotic process begins with the fascia in a 
contracted position (Young et al., 2001). Upon waking, and the first several steps 
in the morning, an insidious onset of pain occurs as the foot moves in a manner 
of dorsiflexion for the first time in six or more hours (Nuhmani, 2014). Such a 
severe sensation may also occur upon commencing any activity involving 
walking or running following a period of non-weight bearing, and unless 
extended periods of weight bearing occur, patients often find that their pain 
subsides or even vanishes (in less severe cases) as the day progresses. It is 
important for physicians to ask about this morning onset of pain in order to 
either identify a patient possibly suffering from plantar fasciitis or exclude it as a 
diagnosis. 
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THERAPIES AND TREATMENT OPTIONS  
 
Stretching 
 Stretching and strengthening programs have long been regarded as a 
necessary component to the treatment of plantar fasciitis, and depending on the 
progression of a patient’s condition, may be sufficient in keeping the symptoms at 
bay while also working to prevent recurrent injury from happening. Regardless of 
the severity of tearing, stretching almost always acts to remove pain, but the timing 
of such stretching can be critical. While many of the stretches detailed below are 
utilized universally, the dosage and duration of stretches will often depend on the 
patient; this can range from two times a day for 20 second intervals to 5+ times a 
day for a sustained (3 minute) period (Nuhmani et al., 2014). 
 Many such stretching and strengthening programs share a focus on the 
gastrocsoleus complex: the combination of the more superficial, superior 
gastrocnemius muscle and the deeper soleus muscle, attached to the calcaneus by 
the Achilles tendon (Cohen, 2009).  Tightness in these muscles, which as a collection 
comprise the calf muscle, can be responsible for worsening of the plantar fasciitis 
condition. This occurs mainly by increasing the degree of plantar flexion in the state 
of a resting foot, thereby causing increased contraction of the fascia and 
subsequently greater pain upon weight bearing and dorsiflexion (Young et al., 
2001). Therefore, stretching the calf can decrease tightness in these muscles, 
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increase the flexibility of the connective tissues comprising the entire plantar 
surface and also build strength in the muscles of the foot. All of these factors 
contribute to lessening pain associated with plantar fasciitis. Several examples of 
the most common techniques prescribed for plantar fascia microtears can be seen in 
Figure 6 (a-f) and almost all of them can be executed in a standard home or 
apartment, making this method of treatment preferred by doctors and patients alike 
because it requires less visits or weekly therapy time in an office. However, the 
downside to this therapy is, without supervision, patients may forget to keep a 
regular stretching schedule or perform the exercises incorrectly. However, as  
 
Figure 6 shows, the stretches are relatively simple and provided a good explanation 
from a physician, unlikely to cause any confusion. 
Figure 6. Common Stretching Techniques targeting the gastrocsoleus complex of the 
calf as well as the plantar tissues, directly (modified from Young et al., 2001). a. stretch 
using a 2 x 2 x 4 inch piece of wood, in which the patient stands upon the piece for 
several minutes to improve flexibility of the calf. b. dynamic stretch using a 15 oz can (or 
tennis ball) to roll under the fascia, duration and amount of pressure applied vary on 
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level of patient pain. c. wall stretches are particularly effective, requiring no equipment, 
and this position focuses on the gastrocnemius while d. focuses on the soleus (note the 
difference in the bend of the knee). e. a typical stair stretch, which again requires no 
equipment. f. similar to the stair stretch but with an adjustable wooden slant board. 
Note that e and f may be used to focus on either the gastrocnemius or soleus, depending 
on the amount of bend allowed in the knee. 
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A 1994 study showed 29% of patients adhering to a stretching schedule 
listed stretching as the most beneficial treatment, compared with the 
implementation of orthotics, nonsteroidal anti inflammatory drugs (NSAIDs), 
ice, and even steroid injection and other procedures. This study was based on 
long-term follow-ups with patients originally presenting with CPHP (Young et 
al., 2001). Of those patients who maintained that stretching schedule, 83 percent 
reported relief from symptoms (Young et al., 2001).  
  
 
 
 
 
 
 
Figure 7. Cross-friction Massage applied directly anterior to the area of acute pain, 
usually in the region of the medial process of the calcaneal tubercle (modified from 
Young et al., 2001). 
 
A critical factor for many patients is the timing at which these stretches 
are performed. As discussed previously, for many patients, pain is often worse in 
the morning, before the first steps of the day. For this reason a massaging 
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technique, shown in Figure 7, has been developed to relieve pain before those 
agonizing first steps. In concordance, the stretches detailed above provide the 
most relief when utilized after a period of rest and/or before a period of weight 
bearing or exercise (Irving et al., 2006).  
 
Arch Supports, Orthotics, and Night Splints 
 When plantar fasciitis microtears are allowed to develop beyond the 
initial acute phase, patients may require more constant support and therapy than 
a regimen of stretching exercise throughout the day, although no matter the 
progression of the condition, stretching is almost always prescribed. One method 
that physicians use to supplement stretching and provide their patients with 
support throughout the day, especially during weight bearing activities, is the 
prescription of arch supports or orthotics. Orthotic devices range in cost and 
style but all function similarly to reduce abnormal foot pronation (Figure 8), and 
consequently excessive pressure on the plantar fascia (Nuhmani et al., 2014). 
Both over-the-counter and customized supports alike, designed to be worn in a 
shoe, have been shown to improve the symptoms of plantar fasciitis patients, and 
may eventually lead to full recovery from the condition and independence from 
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such supports (Jabbari, 2015). As stated by Nuhmani et al., the goals of a 
physician when prescribing orthotics are: 
• To promote proper biomechanical alignment of the foot (neutral)  
• To achieve maximum comfort by using materials that absorb shock  
• To provide cushioning and comfort exactly to the contour of the foot  
• To attain time and cost efficiency (Nuhmani et al., 2014) 
These guidelines are important for physicians to keep in mind because of the 
proven efficacy these supports have been shown to have: a widespread study of 
more than 200 patients found orthotics combined with stretching to be 
significantly more effective than stretching alone (P=0.022) (Pfeffer et al., 1999). 
 
Figure 8. Orthotic Support provided to the medial band of the plantar fascia, which 
reduces stress during static loading, prevents excessive pronation, and prevents the 
collapse of the MLA (modified from Chaplin, 2017). 
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 General practitioners and family doctors untrained in podiatric medicine 
may refer a patient to an orthopedic surgeon or outpatient physical therapy clinic 
to have customized orthotics built specifically for their feet. In such instances, a 
complete biomechanical examination is warranted, including the inspection of 
the forefoot-rearfoot relationship as well as the range of motion of the first 
metatarsophalangeal, midtarsal, subtalar and ankle joints (Barrett et al., 1999). It 
is important for the foot to be cast properly, with the subtalar joint in the neutral 
position (i.e. the foot showing neither pronation nor supination, plantar flexion 
nor dorsiflexion) (Barrett et al., 1999). This ensures proper dispersion of the force 
applied on heel strike, with a diminished abnormal compensatory force, which 
may be partially or wholly responsible for the microtrauma in the fascia tissue 
(Barrett et al., 1999).  
 For patients who experience the classic plantar fasciitis symptom of the 
painful first step, a dorsiflexion night splint may be prescribed. Such splints may 
be customized for an individual patient, however many orthopedic offices sell 
commercially produced models, which are also fairly easily found over-the-
counter and online as well. Such a splint may be worn unilaterally if only one 
side is affected and act to prevent plantar flexion, and subsequent consequences 
as discussed in the physiology section, during a night’s sleep (Young et al., 2001). 
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This extended dorsiflexion serves a dual purpose; by keeping the foot around 90 
degrees or greater (varying on the type of splint, see Figure 9) not only does the 
plantar fascia remain elongated, as in periods of activity or weight bearing, but 
also the gastrocsoleus complex of the calf is stretched (Young et al., 2001). 
Therefore, while healing of the fascia is allowed to occur at a functional length, 
one of the greatest residual issues associated with plantar fasciitis, tightness in 
the calf muscles, is treated as well. Although not painful, some patients (and 
their bed partners) have reported such splints to be uncomfortable to sleep in, 
which is one reason why a few different styles of splints have evolved (Figure 9). 
Despite the reported lack of comfort, in two separate studies, improvement was 
shown in over 80% of the population of patients wearing the splints, (Young et 
al., 2001) (Barrett et al., 1999). Interestingly, both studies showed a correlation 
with improvement in patients who had symptoms for at least 12 months, 
respectively. Another study of patients with more recently developed symptoms 
showed almost no improvement over three months, and night splints have 
proven to be most effective when used in combination with a walking orthotic 
(Nuhmani et al., 2014).  
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Figure 9. Commercially Produced Night Splints in two different styles: dorsal (left) and 
soft (right). Similar models to these generic examples are available on many different 
websites, ranging from $15 to $100 (taken from Power Medical Supplies). 
 
Corticosteroid Injections 
 While several other treatment options may be recommended once a 
plantar fasciitis patient progresses past the acute phase, none is more contested 
or studied as often the local application of a corticosteroid. While these injections 
often relieve all pain for a minimum of two weeks and are much more effective 
in promoting proper healing of microtrauma when administered early on in the 
course of the injury, they are often only used sparingly, as a last resort, in 
patients with plantar fasciitis which has progressed to the subacute, and even the 
chronic stage (Young et al., 2001). This is because of the abundance of risks 
associated with these procedures, discussed below. 
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 Throughout the literature, corticosteroid injections are commonly referred 
to only when discussing recalcitrant cases of plantar fasciitis. In these patients, 
more conservative treatment has proven insufficient and their pain has escalated 
well beyond the acute phase. Young et al. recommends physicians considering 
this treatment request a plain radiograph of the foot, and specifically the 
calcaneus, before proceeding (Young et al., 2001). Such a scan ensures the source 
of the pain is indeed plantar fasciitis and rules out other sources such as tumors 
or bone spurs (Young et al., 2001). Magnetic resonance imaging (MRI) may be 
used instead, and both imaging techniques can show the morphological changes 
associated with plantar fasciitis. One risk when it comes to performing such 
injections lies between two methods of determining the insertion point of the 
needle and improper placement of the injection is one of the main factors 
responsible for several of the associated risks, discussed below (Li et al., 2014). 
Palpation-guided injection has been used for decades to treat plantar fasciitis, 
and its supporters argue that it is just as effective as ultrasound-guided injection, 
while being far less expensive (Li et al., 2014). This thinking, however, is 
changing as a recent meta-analysis compared the efficacy of palpation-guided 
injections versus ultrasound-guided injections. The argument for using 
ultrasound as a guide is simple; the distinct features of plantar fasciitis (increased 
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thickness, obscure borders and hypoechogenicity of plantar fascia) can be 
visualized easily with ultrasound (Figure 10), and the scarcity and the associated 
high cost of MRI are becoming a thing of the past with almost every modern 
medical facility having access to one (Li et al., 2014). That meta-analysis found 
that both palpation-guided and ultrasound-guided could be equally effective, 
when administered precisely, however there is a much greater propensity for 
error when it comes to the non-ultrasound-guided technique (Li et al., 2014). In 
one study, four patients (three of whom suffered unilaterally, with one suffering 
bilaterally) were administered triamcinolone acetonide by way of an ultrasound-
guided injection. All four of the patients had been unresponsive previously to 
palpation-guided injection, but four of the five heels treated with an ultrasound-
guided injection had complete pain relief (Li et al., 2014). Although a small 
sample size, this study was in accordance with several others cited in Li et al.’s 
paper and showed a higher efficacy of ultrasound-guided injections compared 
with those guided by palpation (2014). Furthermore, ultrasound can be a 
powerful tool to determine the effect an injection has had on a patient, especially 
those treated relatively early on in the course of the injury.  
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Figure 10. Ultrasound Image of Plantar Fasciitis showing a thickened plantar fascia 
(taken from McMillan et al., 2010) 
 
 
 A typical injection consists of 3.0 mL of an equal mixture of 1% lidocaine, 
0.5% marcaine and 1 mL of triamcinolone (40 mg per mL), although as stated 
earlier, triamcinolone acetonide and betamethasone may be used as well (Barrett 
et al., 1999). Regardless of the method of determining where to administer the 
injection, there are risks associated with such a therapy. To avoid fat pad 
atrophy, and subsequent loss of support and cushioning, it is important for a 
clinician to administer the injection from the medial, rather than the inferior 
aspect of the calcaneus, including several small withdrawals and reinsertions 
(Singh et al., 1997). These minor movements allow the injection to permeate the 
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superior aspect of the inflamed aponeurosis while circumventing the inferior 
aspect (the region of the fat pad). Another major risk involved with 
corticosteroid injections is rupture of the plantar fascia. Nearly 10% of patients in 
one study suffered rupture of the tissue following injection, and although 
healing is possible through rehabilitation, that injury can be extremely painful 
(Young et al., 2001). 
 It appears that steroid injections can vastly improve the symptoms of 
patients suffering from plantar fasciitis in the short term, albeit at a risk of more 
severe injury and other complications in the longer term. More recently, a 
relatively novel injection treatment (botulinum toxin A) has been developed and 
a study of its efficacy has provided encouraging results. In one study conducted 
at the Walter Reed Army Medical Center, the efficacy of onabotulinumtoxinA 
was tested by comparing the results of patients injected with a specified amount 
of the drug versus a control group of patients injected with saline (Jabbari, 2015). 
All patients that participated had been afflicted by plantar fasciitis symptoms for 
at least six months and for each affected foot, two injections were made. The first 
dose was delivered to the traditional area of injection, the center of pain near the 
calcaneal tuberosity. The second injection, which received slightly lower dosage, 
lay between the posterior line of the calcaneus and the middle of the foot (Figure 
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11) (Jabbari, 2015). Four measures of pain were assessed before treatment, at 
three weeks, and at eight weeks: Pain visual analog scale, Maryland Foot Score, 
pain relief visual analog scale, and pressure algometry response (Jabbari, 2015). 
 
 
 
 
 
 
 
Figure 11. Site of OnabotulinumtoxinA Injection in affected feet in the cited study. 
Note the more traditional site (posterior) and the more medial site (modified from 
Jabbari, 2015). 
 
The results were remarkable; the onabotulinumtoxinA group showed 
statistically significant improvements in all four measurements of pain when 
compared to the control (Jabbari, 2015). The most astounding finding was a lack 
of any side effects, notably those associated with corticosteroid injections (fat pad 
atrophy, plantar fascia rupture). A separate study using a single injection at the 
more traditional, posterior site showed similar findings, including statistically 
significant decreases in plantar fascia thickness, indicating healing of the 
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condition, instead of a simple masking of the symptoms (Jabbari , 2015). While 
botulinum toxin A has been deemed safe and effective for treatment, more long-
term studies are necessary to make it a more widely practiced treatment option. 
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CONCLUSION 
 Through this review of literature, several consistencies were noticed. 
Firstly, the reported incidence of plantar fasciitis, while large, is almost surely an 
underestimation. Its risk factors, especially a BMI >30 and an active running 
lifestyle, make it a condition that affects a wide range of patients in today’s 
varied American society. From diabetes specialists treating the chronically obese 
to orthopedic surgeons consulting hyperactive athletes, healthcare professionals 
of all fields should be prepared to discuss the mechanisms, probable causes, and 
treatment options for plantar fasciitis. Another consistency of the literature is the 
relatively simple, practical, and very affordable methods that exist for treating 
this injury. It seems that, if diagnosed early on in the acute phase, plantar fasciitis 
is an extremely easily treatable condition. Indeed, stretching and possibly an 
inexpensive over-the-counter arch support would be enough to tackle a majority 
of cases in the acute phase. Unfortunately, due to a combination of patients 
presenting late and an inconsistent guide for diagnosing and differentiating 
plantar fasciitis from other seemingly similar heel injuries, far too many patients 
progress into the subacute phase before viable treatment methods are put into 
action. This inconsistent methodology behind the diagnosis of the condition and 
perhaps the patient’s willingness to put up with pain for some time before 
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seeking medical care most likely contribute to the severity of many cases. The 
answer to this dilemma, I believe, is education of the medical community on the 
basics of this injury. Namely, it is a misnomer and not, as some of the literature 
states nonchalantly, inflammation of the plantar fascia, but rather a fasciosis. This 
means it is much more similar to the chronic necrosis of tendinosis than 
tendinitis, a classic example of inflammation. Tendinosis and tendinitis are 
treated differently and specifically according to their definitions and it seems that 
the misunderstood definition of plantar fasciitis as a major impediment to the 
care of patients suffering its symptoms. Armed with a clear understanding of 
plantar fasciitis’ risk factors and physiology, I believe healthcare professionals 
will be well equipped to identify and correct this disorder, at a low cost to their 
patient.  
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